{
  "pmcid": "11529789",
  "sha256": "4ded0b130505559f04e87e972d80e94888de98f45dd8e4251a7fffdd023a242c",
  "timestamp_utc": "2025-11-09T15:20:35.985528+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 16.655325419566108,
    "reading_ease": 5.252626552053499,
    "word_count": 349
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients with periampullary tumours who underwent open pancreatoduodenectomy were randomly allocated"
      },
      "Participants": {
        "score": 1,
        "evidence": "Patients with periampullary tumours who underwent open pancreatoduodenectomy"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly allocated to either the no-touch approach or the superior mesenteric artery approach"
      },
      "Objective": {
        "score": 1,
        "evidence": "The aim of this study was to assess two pancreatoduodenectomy approaches"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Primary outcomes were the intraoperative number of circulating tumour cells and cluster mobilization"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "randomly allocated to either the no-touch approach or the superior mesenteric artery approach"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 101 patients with periampullary tumours were randomized"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "63 patients with pancreatic ductal adenocarcinoma (34 in the superior mesenteric artery group and 29 in the no-touch group) were analysed"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "median metastasis disease-free survival (12.4 (interquartile range 6.1–not reached) months in the superior mesenteric artery group and 18.1 (interquartile range 12.1–not reached) months in the no-touch group; P = 0.730)"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Registration number: NCT03340844 ( http://www.clinicaltrials.gov )"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 14,
    "max_score": 25
  }
}